All Stories

  1. Effect of Aging on Deferasirox Therapy in Transfusion-dependent Patients. A Prospective- Retrospective, Cohort-study

    Article • Current Drug Metabolism, November 2022, Bentham Science Publishers

    Valeria Pinto, Dr Gian Luca Forni, Francesca Mattioli

  2. Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion-dependent thalassemia patients

    Article • American Journal of Hematology, August 2018, Wiley

    Valeria Pinto, Dr Gian Luca Forni

  3. A Rapid, Affordable and Feasible Method for Detection of the HBG1: g.-225_-222delAGCA Polymorphism

    Article • Hemoglobin, July 2018, Taylor & Francis

    Dr Gian Luca Forni

  4. Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias

    Article • American Journal of Hematology, May 2018, Wiley

    Dr Gian Luca Forni, Rakesh Khuntia

  5. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias

    Article • American Journal of Hematology, February 2018, Wiley

    Dr Gian Luca Forni, Roberta Russo

  6. Pseudoxanthoma Elasticum-Like in β-Thalassemia Major, a matter of α-Klotho and Parathyroid Hormone?

    Article • Hemoglobin, November 2017, Taylor & Francis

    Dr Gian Luca Forni, Dr Andrea Giusti

  7. Noninvasive monitoring of liver fibrosis in sickle cell disease: Longitudinal observation of a cohort of adult patients

    Article • American Journal of Hematology, October 2017, Wiley

    Dr Gian Luca Forni

  8. Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies

    Article • American Journal of Hematology, October 2017, Wiley

    Dr Gian Luca Forni, Valeria Pinto

  9. Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey

    Article • Pediatric Blood & Cancer, September 2017, Wiley

    Dr Raffaella Colombatti, Giovanna Russo, Dr Gian Luca Forni

  10. Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry

    Article • British Journal of Haematology, July 2014, Wiley

    Dr Gian Luca Forni

  11. Development of interactive algorithm for clinical management of acute events related to sickle cell disease in emergency department

    Article • Orphanet Journal of Rare Diseases, June 2014, Springer Science + Business Media

    Dr Gian Luca Forni

  12. Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up

    Article • Parkinsonism & Related Disorders, June 2014, Elsevier

    Dr Gian Luca Forni

  13. Diagnostic value of real-time elastography in the assessment of hepatic fibrosis in patients with liver iron overload

    Article • European Journal of Radiology, December 2013, Elsevier

    Dr Gian Luca Forni

  14. Transferrin‐immune complex disease: A potentially overlooked gammopathy mediated by IgM and IgG

    Article • American Journal of Hematology, October 2013, Wiley

    Dr Gian Luca Forni

  15. Assessment and management of iron overload in β‐thalassaemia major patients during the 21st century: a real‐life experience from the Italian Webthal project

    Article • British Journal of Haematology, April 2013, Wiley

    Dr Gian Luca Forni

  16. Neridronate improves bone mineral density and reduces back pain in β‐thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel‐arm, open‐label study

    Article • British Journal of Haematology, May 2012, Wiley

    Dr Gian Luca Forni

  17. Congenital Dyserythropoietic Anemia Type II: molecular analysis and expression of the SEC23B Gene

    Article • Orphanet Journal of Rare Diseases, December 2011, Springer Science + Business Media

    Dr Gian Luca Forni

  18. Changing patterns of splenectomy in transfusion‐dependent thalassemia patients

    Article • American Journal of Hematology, August 2011, Wiley

    Dr Gian Luca Forni

  19. Response of iron overload to deferasirox in rare transfusion‐dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias

    Article • European Journal Of Haematology, July 2011, Wiley

    Dr Gian Luca Forni

  20. Risk factors for cholangiocarcinoma

    Article • Hepatology, June 2011, Wolters Kluwer Health

    Dr Gian Luca Forni

  21. Long‐term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease

    Article • British Journal of Haematology, May 2011, Wiley

    Dr Gian Luca Forni

  22. Worldwide survey of T2* cardiovascular magnetic resonance in Thalassaemia

    Article • Journal of Cardiovascular Magnetic Resonance, February 2011, Elsevier

    Dr Gian Luca Forni

  23. Analysis of Nucleotide Variations in Genes of Iron Management in Patients of Parkinson's Disease and Other Movement Disorders

    Article • Parkinson s Disease, January 2011, Hindawi Publishing Corporation

    Dr Gian Luca Forni

  24. Sequence Variations in Mitochondrial Ferritin: Distribution in Healthy Controls and Different Types of Patients

    Article • Genetic Testing and Molecular Biomarkers, December 2010, Mary Ann Liebert Inc

    Dr Gian Luca Forni

  25. Manual erythroexchange for chronic transfusion therapy in patients with sickle cell syndromes unresponsive to hydroxyurea: A long‐term follow‐up

    Article • American Journal of Hematology, November 2010, Wiley

    Dr Gian Luca Forni

  26. Mutational spectrum in congenital dyserythropoietic anemia type II: Identification of 19 novel variants in SEC23B gene

    Article • American Journal of Hematology, October 2010, Wiley

    Dr Gian Luca Forni, Roberta Russo

  27. Venous-Like Leg Ulcers without Venous Insufficiency in Congenital Anemia: Successful Treatment Using Compression Bandages

    Article • Dermatologic Surgery, August 2010, Wolters Kluwer Health

    Dr Gian Luca Forni

  28. Daily alternating deferasirox and deferiprone therapy for “hard‐to‐chelate” β‐thalassemia major patients

    Article • American Journal of Hematology, April 2010, Wiley

    Dr Gian Luca Forni

  29. The influence of treatment in specialized centers on survival of patients with thalassemia major

    Article • American Journal of Hematology, April 2009, Wiley

    Dr Gian Luca Forni

  30. Calibration of myocardial iron concentration against T2-star Cardiovascular Magnetic Resonance

    Article • Journal of Cardiovascular Magnetic Resonance, January 2009, Elsevier

    Dr Gian Luca Forni

  31. Cholelithiasis in thalassemia major

    Article • European Journal Of Haematology, December 2008, Wiley

    Dr Gian Luca Forni

  32. Acquired iron overload associated with antitransferrin monoclonal immunoglobulin: A case report

    Article • American Journal of Hematology, October 2008, Wiley

    Dr Gian Luca Forni

  33. Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation

    Article • Movement Disorders, April 2008, Wiley

    Dr Gian Luca Forni

  34. Effect of Food, Type of Food, and Time of Food Intake on Deferasirox Bioavailability: Recommendations for an Optimal Deferasirox Administration Regimen

    Article • The Journal of Clinical Pharmacology, April 2008, Wiley

    Dr Gian Luca Forni

  35. Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional Hemosiderosis

    Article • Acta Haematologica, January 2008, Karger Publishers

    Dr Gian Luca Forni

  36. Standardized T2* Map of a Normal Human Heart to Correct T2* Segmental Artefacts; Myocardial Iron Overload and Fibrosis in Thalassemia IntermediaVersusThalassemia Major Patients and Electrocardiogram Changes in Thalassemia Major Patients

    Article • Hemoglobin, January 2008, Taylor & Francis

    Dr Gian Luca Forni

  37. Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study

    Article • European Journal Of Haematology, December 2007, Wiley

    Dr Gian Luca Forni, Dr Ellis J Neufeld

  38. Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts

    Article • NMR in Biomedicine, January 2007, Wiley

    Dr Gian Luca Forni

  39. A randomised comparison of deferasiroxversusdeferoxamine for the treatment of transfusional iron overload in sickle cell disease

    Article • British Journal of Haematology, December 2006, Wiley

    Dr Gian Luca Forni

  40. Therapeutic Approaches to Pulmonary Hypertension in Hemoglobinopathies: Efficacy and Safety of Sildenafil in the Treatment of Severe Pulmonary Hypertension in Patients with Hemoglobinopathy

    Article • Annals of the New York Academy of Sciences, November 2005, Wiley

    Dr Gian Luca Forni

  41. Genetic and clinical heterogeneity of ferroportin disease

    Article • British Journal of Haematology, October 2005, Wiley

    Dr Gian Luca Forni

  42. Lack of Prognostic Value of Normalized Integrated Backscatter Analysis of Myocardium in Patients with Thalassemia Major: A Long‐Term Follow‐Up Study

    Article • Echocardiography, February 2005, Wiley

    Dr Gian Luca Forni, Dr Lamia Ait Ali

  43. Hepatocellular carcinoma in the thalassaemia syndromes

    Article • British Journal of Haematology, December 2003, Wiley

    Dr Gian Luca Forni

  44. Typical manifestation of acute congestive heart failure in patients with Thalassaemia major causing diagnostic delay in the emergency room

    Article • European Journal of Heart Failure, October 2003, Wiley

    Dr Gian Luca Forni

  45. Pulmonary hypertension in patients with thalassemia major

    Article • American Heart Journal, August 1999, Elsevier

    Dr Gian Luca Forni

  46. Nonrandom X‐Chromosome Inactivation in Hemopoietic Cells from Carriers of Dyskeratosis Congenita

    Article • The American Journal of Human Genetics, August 1997, Elsevier

    Dr Gian Luca Forni

  47. Nonrandom X-Chromosome Inactivation in Hemopoietic Cells from Carriers of Dyskeratosis Congenita

    Article • The American Journal of Human Genetics, August 1997, Elsevier

    Dr Gian Luca Forni

  48. Quantitative Texture Analysis in Two‐Dimensional Echocardiography

    Article • Echocardiography, January 1996, Wiley

    Dr Gian Luca Forni

  49. G6PD deficiency‐related chronic hemolysis treated with splenectomy: A case report

    Article • American Journal of Hematology, October 1994, Wiley

    Dr Gian Luca Forni

  50. Dyskeratosis Congenita: Unusual Presenting Features Within a Kindred

    Article • Pediatric Hematology and Oncology, January 1993, Taylor & Francis

    Dr Gian Luca Forni

  51. Increased ultrasonic myocardial reflectivity in patients with thalassemia major and iron overload

    Article • Journal of the American College of Cardiology, February 1991, Elsevier

    Dr Gian Luca Forni

  52. Widespread multitissue deletions of the mitochondrial genome in the Pearson marrow-pancreas syndrome

    Article • The Journal of Pediatrics, October 1990, Elsevier

    Dr Gian Luca Forni

  53. A new glucose-6-phosphate dehydrogenase variant with congenital nonspherocytic hemolytic anemia (G6PD Genova)

    Article • Human Genetics, March 1990, Springer Science + Business Media

    Dr Gian Luca Forni